No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor*
-
Fas Ligand Protein / blood*
-
Female
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / blood*
-
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
-
Male
-
Prognosis
-
Treatment Outcome
-
Vidarabine / administration & dosage
-
Vidarabine / analogs & derivatives
Substances
-
Biomarkers, Tumor
-
FASLG protein, human
-
Fas Ligand Protein
-
Vidarabine
-
fludarabine